Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and ...
Quick Fixes: Drugs in America from Prohibition to the 21st-Century Binge, by Benjamin Y. Fong (Jacobin, 264 pp., $24.95) Drugs make for easy symbols. Breaking Bad, the mid-aughts prestige TV hit about ...
Drug shortages have decreased but remain significant, with 50% persisting over two years, affecting critical medications. Shortages stem from product-specific issues, market constraints, and access ...
FDA reviewers flagged trial uncertainties for nearly 80% of cancer drugs approved from 2019 to 2022, but few were reported in journals or National Comprehensive Cancer Network (NCCN) guidelines. The ...
In this issue of the Journal, Bramante et al. 6 report the results of the COVID-OUT randomized, controlled trial of oral metformin, ivermectin, and fluvoxamine for the early treatment of SARS-CoV-2 ...
“Our approach has allowed us to build a comprehensive atlas mapping the associations of GLP-1RA spanning all organ systems,” said the study’s senior author, Ziyad Al-Aly, MD, a clinical epidemiologist ...
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Janina Rager: Right now this morning we're just going to do a drive-through ...
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Kate Linebaugh: Elon Musk is the wealthiest man in the world. Much of that wealth ...
Pharma sees huge potential in AI tools to find drug candidates & shorten development. Can AI be a miracle cure?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results